Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Kopran Limited ( (IN:KOPRAN) ) has issued an announcement.
Kopran Limited has announced the submission of a Draft Scheme of Amalgamation, which involves the merger of Kopran Laboratories Limited into Kopran Limited. This strategic move is expected to streamline operations and enhance the company’s market position, subject to necessary approvals from regulatory authorities and stakeholders.
More about Kopran Limited
Kopran Limited operates in the pharmaceutical industry, focusing on the development and manufacturing of pharmaceutical products. The company is known for its range of formulations and active pharmaceutical ingredients, serving both domestic and international markets.
YTD Price Performance: -4.70%
Average Trading Volume: 26,830
Current Market Cap: 9.91B INR
See more insights into KOPRAN stock on TipRanks’ Stock Analysis page.